Siguldas CMAS

Interim / Quarterly Report • Aug 14, 2014

Joint stock company SIGULDAS CILTSLIETU UN MĀKSLĪGĀS APSĒKLOŠANAS STACIJA

INTERIM STATEMENT for 6 months of 2014

Index of Contents

Page
3
4
5
6
8
9
10
22

Information on the Company

Company's name	SIGULDAS CILTSLIETU UN MĀKSLĪGĀS APSĒKLOŠANAS STACIJA
Company's legal status	Joint stock company
	40003013295, Riga, 26 July 1991
Registration number, place and date	Registration in the Commercial Register on 19 June 2004
Legal address	"Kalnabeites"8, Sigulda parish, Sigulda area, LV-2150
Shareholders holding more than 5% of the total number of voting shares	SIA "Siguldas mākslīgās apsēklošanas stacija" (49.8%), registration No. 40003311954
	Oļegs Radčenko (5.18%)
Members of the Board	Nils Ivars Feodorovs, Chairman of the Board Sarmīte Arcimoviča, Member of the Board Valda Mālniece, Member of the Board
Members of the Council	Inita Bedrīte, Chairman of the Council Maija Beča, Deputy Chairman of the Council Ērika Everte, Member of the Council Solvita Arcimoviča, Member of the Council Jekaterina Kreise, Member of the Council
Reporting year	01.01.2014 – 30.06.2014
Auditors	Anita Sondore Sworn Auditor Certificate No. 129
	AUDITS A.S., SIA "Pīlādži", Līgatne parish, Līgatne area, LV-4108, Latvia Sworn Auditors' Commercial Company's license No. 27

Interim Management Report

The basic economic activity of the Stock Company invariably is the production and sale of the bull semen, comprising 53% of its net turnover in the accounting period, as well as the milk assay and data processing services, which, taken together, comprise 36% of company's net turnover. The proportion of the company's basic activities, if compared with the one of the first six months of 2013, do not show any significant changes.

Company's net turnover in the first half-year of 2014 was 549 thousand EUR, showing an increase of 6% against the corresponding period in 2013, while company's profit of 85 thousand EUR of the first six months of 2014 comprise an increase of 102% against the corresponding period in 2013.

The commercial profitability in the first six months of 2014 was 17%, compared to 10% in 2013.

Along with the expansion of its market share in Latvia, company has increased its revenue from the sales of the bull semen by 10%. The purchase of a modern production machinery and well concluded deals on purchase of bulls from abroad have resulted in the increase in the proportion of the company's home-produced bull semen, comprising 79% of the total dosages sold.

Chairman of the Board Member of the Board Member of the Board

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece

Profit or loss account for the period ended 30 June 2014

	Note	2014 EUR	2013 EUR
Net sales	3	549 248	516 491
Changes in stock of ready-made goods and unfinished products	4	43 914	36 368
Other operating income	5	4 300	3 491
Costs of materials:		(230 128)	(241 275)
a) raw materials and auxiliary costs of materials		(174 025)	(187 294)
b) other external costs		(56 103)	(53 981)
Personnel costs:	6	(226 190)	(215 164)
a) salaries for work		(177 030)	(167 774)
b) state social insurance compulsory contributions		(39 969)	(38 460)
c) other social insurance costs		(9 191)	(8 930)
Write-off of assets and values:		(22 479)	(25 178)
a) depreciation of fixed assets and amortization of intangible assets		(22 479)	(24 978)
b) write-off of value of current assets above the normal deductions		-	(200)
Other operating costs	7	(24 388)	(23 001)
Other interest income and similar income	8	2 422	1 399
Interest payments and similar costs	9	(2 515)	(2 268)
Profit or losses before taxes		94 184	50 863
Enterprise income tax for the reporting year		(7 872)	(7 245)
Other taxes	10	(1 635)	(1 612)
The profit or loss for the year		84 677	42 006
Equity per 1 share (EPS)	22	0.200	0.099

Notes on pages 10 to 21 form an integral part of these financial statements.

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece Chairman of the Board Member of the Board Member of the Board

Balance sheet as at 30 June 2014

Long-term investments Fixed assets Land parcels, buildings and constructions and perennial plantings 148 830 166 324 Equipment and machinery 49 306 44 503 Other fixed assets and inventory 10 646 8 828 Fixed assets in formation 1 668 29 171 Fixed assets total 12 210 450 248 826 13 Investment properties 86 795 120 944 Biological assets 86 165 74 670 Long-term financial investments Investments in capital of associated companies 14 83 954 83 954 Other securities and investments 15 683 683 Long-term financial investments total 84 637 84 637 Long-term investments total 468 047 529 077 Current assets Stock Raw materials, basic materials and auxiliary materials 12 304 10 194 Ready-made goods and goods for sale 16 560 157 518 535 Prepayments for goods 1 578 1 297 Stock total 574 039 530 026 Receivables Trade receivables 17 199 944 166 177 Other receivables 18 391 1 727 Prepaid expenses 19 3 443 3 629 Receivables total 203 778 171 533 Short-term financial investments Other securities and shareholding in capitals 20 31 142 31 102 Short-term financial investments total 31 142 31 102 Cash 21 203 989 152 288 Current assets total 1 012 948 884 949 Assets total 1 480 995 1 414 026	Assets	Note	2014 EUR	2013 EUR

Balance sheet as at 30 June 2014

Shareholders' equity and liabilities	Note	2014 EUR	2013 EUR
Shareholders' equity
Share capital	22	601 078	601 078
Retained earnings:
Retained earnings carried forward from previous years		711 538	700 585
Retained earnings of the reporting year		84 677	42 006
Shareholders' equity total		1 397 293	1 343 669
Provisions
Other provisions	23	6 926	8 176
Provisions total		6 926	8 176
Payables
Long-term payables
Deferred tax liabilities	24	4 550	4 353
Long-term payables total		4 550	4 353
Short-term payables
Prepayment received from customers		397	569
Trade payables		32 998	15 529
Taxes and social insurance payments	25	27 135	31 999
Other payables		11 696	9 731
Short-term payables total		72 226	57 828
Payables total		76 776	62 181
Shareholders' equity and liabilities total		1 480 995	1 414 026

Notes on pages 10 to 21 form an integral part of these financial statements.

Chairman of the Board Member of the Board Member of the Board

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece

Cash flow statement for the period ended 30 June 2014

	Note	2014 EUR	2013 EUR
Cash flow from operating activities
Income from sale of goods and provision of services		609 814	572 359
Payments to suppliers, employees, other expenses arising from basic operations		(605 119)	(620 335)
Gross cash flow from basic operations		4 695	(47 976)
Expenses for enterprise income tax payments		(6 873)	(9 541)
Net cash flow from operating activities		(2 178)	(57 517)
Cash flow from investing activities
Purchase of capital shares of associated company		-	(552)
Purchase of fixed assets and intangible investments		(4 585)	(31 123)
Net cash flow from investing activities		(4 585)	(31 675)
Cash flow from financing activities
Subsidies received as a state support		4 300	3 491
Dividends paid		(59 142)	(60 108)
Net cash flow from financing activities		(54 842)	(56 617)
Result of foreign exchange rate fluctuations		(310)	(268)
Increase/ decrease of cash and its equivalents		(61 915)	(146 077)
Cash and its equivalents at the beginning of the period		265 904	298 365
Cash and its equivalents at the end of the period	21	203 989	152 288

Notes on pages10 to 21 form an integral part of these financial statements.

Chairman of the Board Member of the Board Member of the Board

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece

Statement on changes in shareholders' equity for the period ending 30 June 2014

	Share capital	Retained earnings carried forward from previous years	Retained earnings for the reporting year	Shareholders' equity total
	EUR	EUR	EUR	EUR
31.12.2012	601 078	678 906	81 787	1 361 771
Profit for 2012 transferred to retained earnings of previous years Dividends for 2012 Retained earnings for the reporting year	- - -	81 787 (60 108) -	(81 787) - 42 006	- (60 108) 42 006
30.06.2013	601 078	700 585	42 006	1 343 669
31.12.2013	601 078	700 585	70 095	1 371 758
Profit for 2013 transferred to retained earnings of previous years Dividends for 2013 Retained earnings for the reporting year	- - -	70 095 (59 142) -	(70 095) - 84 677	- (59 142) 84 677
30.06.2014	601 078	711 538	84 677	1 397 293

Notes on pages 10 to 21 form an integral part of these financial statements.

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece Chairman of the Board Member of the Board Member of the Board

(1) General information on the Company

AS "Siguldas ciltslietu un mākslīgās apsēklošanas stacija" (hereinafter - the Company) was registered in the Register of Enterprises of the Republic of Latvia on 26 July 1991 and was reregistered in the Commercial Register of the Republic of Latvia on 19 June 2004.

The Company's basic activities are agriculture and the types of business are as follows:

• Production and sale of agricultural products high-quality breeding animals semen,
• making of milk analyses,
• evaluation of cow exterior,
• artificial insemination of cows,
• milk recording data processing,
• animals breeding organization.

(2) Significant accounting principles

Underlying principles of preparation of the Financial Statements

The Company's Financial Statements have been prepared according to the Law On Annual Reports of the Republic of Latvia. The Profit or Loss Account was prepared based on the period costs method. The Cash Flow Statement was prepared according to the direct method.

Accounting principles used

The items of the Financial Statements have been evaluated according to the following accounting principles:

• It is assumed that the Company will be a going concern;
• The same evaluation methods have been used, which were used in the previous year;
• Evaluation was done with sufficient prudence:
  • The Financial Statements include solely the profit gained until the balance sheet date,
  • All expected risk amounts and losses have been taken into account, which occurred during the reporting year or in previous years, also if they were known during a certain period of time between the balance sheets date and the day of preparing the Financial Statements,
  • All value decreasing and depreciation amounts have been taken into account irrespective whether the reporting year was closed with profit or loss;
• reporting year related income and costs were recognized irrespective of the payment date and the date of receipt or issuance of invoice. Costs have been agreed with the income in the reporting period;
• components of asset and liabilities items have been recognized separately;
• the opening balance of the reporting year agrees with the closing balance of the previous year;
• all items have been recognized, which materially influence assessment or decision-making process of the users of the annual report, insignificant items are merged and they are detailed in the Appendix;
• operating transactions in the reporting year have been recognized in the Financial Statements by taking into account their economic substance and contents, rather than legal form.

Financial instruments

Fair value of financial assets and liabilities

Fair value of financial assets and liabilities reflect the amount, for which it is possible to exchange assets or perform liabilities in a deal between well informed, interested and financially independent persons. If in the Company's management opinion, fair value of financial assets and liabilities materially differs from the value recognized in the balance sheet, then the fair value of these assets and liabilities is recognized in the Notes to the Financial Statements.

Financial risks management

Credit risk

The Company's management has developed credit policy, which is constantly controlled. Client evaluation is done for all customers above a fixed amount. The Company cooperates with clients who have proper credit assessment.

Currency risk

Based on the current structure of Company's financial assets and liabilities held in foreign currencies, the currency risk is not material.

Reporting period

The reporting period is 6 months from 1 January to 30 June 2014.

Revaluation of foreign currencies

The Company's functional currency and the currency used in the Financial Statements is euro (EUR) – the sole legal mean of payment in the Republic of Latvia since January 1, 2014. All transactions in foreign currencies are converted into euro according to the euro foreign exchange reference rate published by the European Central Bank on the day of particular transaction being performed.

All showings of the year 2013 have been converted into euro according to the fixed foreign exchange rate for converting lats into euro (1 EUR = 0.702804 LVL) determined by the Council of the European Union.

Monetary assets and liabilities, which are shown in foreign currencies, are converted into euro according to the fixed euro foreign exchange reference rate published by the European Central Bank on the last day of the reporting period.

	30.06.2014	30.06.2013
USD	1.3658	1.3039

Currency exchange rate differences arising from settlements in currencies or when recognizing assets and liabilities by using currency exchange rates, which differ from the initial currency exchange rates used for accounting of transactions, are recognized in the profit or loss account in net value.

Recognition of income

Income is recognized according to the conviction about the Company's possibility to gain economic benefit and in the amount, in which it is possible to state it, less value added tax and sales-related discounts. When recognizing income, also the following provisions are taken into account.

Sale of goods

Income is recognized when the Company has transferred to the purchaser major risks and indemnities related to the title of goods.

Provision of services

Income from services is recognized in the period when the services are provided.

Penalty and delay charges

Income from penalty and delay charges is recognized at the moment of their receipt.

Interest

Income is recognized according to the respective period of time.

Long-term and short-term items

Long-term items include amounts whose receipt, payments or write-off terms are due later after the end of the respective reporting year. Amounts, which are receivable, payable or written off during the year, are recognized in short-term items.

Leasing transactions

Financial leasing

In cases when fixed assets are purchased on the conditions of financial leasing and the related risks and return are taken over, these fixed assets are recognized in the value, for which they could be purchased with immediate payment. Leasing interest payments and similar payments are included in the profit or loss account of that period when they occurred.

Intangible assets and fixed assets

In the balance sheet, all intangible assets and fixed assets are reflected at their purchase prices, less depreciation. Depreciation is calculated from the first date of the next month after their commissioning and finished on the first date of the subsequent month after it is excluded from fixed assets. Depreciation is calculated according to the straight line method and is written off during the useful life time of respective fixed assets by choosing the following annual depreciation rates as fixed by the management:

Intangible assets:

Licenses	5 years
Fixed assets:
Buildings and constructions	10, 20, 25, 40 and 59 years
Equipment and machinery	5, 6 and 7 years
Computer hardware and communication equipment	5 years
Inventory and tools	3 and 5 years
Other fixed assets	2 and 3 years

Balances of fixed assets have been counted in the annual count of fixed assets.

Investment properties

Investment properties – land in possession of the stock company, which market value is expected to grow. Investment properties have been filed according to their purchase value. No later than on the end of the year of account the investments properties are being revalued according to their real market value considering any other activities related to particular property. Any changes in the market value of the investments properties are being shown in the profit and loss account.

Biological assets

Biological assets are assets, which are characterized by regeneration and changes in value as a result of growth. The Company in biological assets includes breeding animals – bulls, which are kept for getting agricultural products for sale. Biological assets are recognized in the purchase value.

Stock

Stock is recognized in the lowest cost or net sales value. All stock is assessed by using the average weighted method.

Net sales value is the sales price of stock fixed during normal Company's operations, less the stock completion and selling costs. In cases when the stock net selling value is lower than their cost price, provisions are made for these stocks for decrease of their value down to the net sales value.

All direct costs, which are related to production of breeding animals - bull semen, during the year are booked in the profit or loss account and are adjusted at the end of the year when evaluating stocks according to the lowest sales value or cost price and including them in stocks as "Ready-made goods and goods for sale".

Trade receivables and other receivables

Receivables are recognized in the balance sheet in the amortized value, less provisions for doubtful and bad debts. Provisions for doubtful and bad debts are made in cases when there is objective evidence to the fact that the Company will not be able to receive the debts in full value according to the initially fixed repayment dates. Provisions for doubtful and bad debts are the difference between the amortized purchase value of receivables and the recoverable value. The recoverable value of receivables is the current value of planned cash flow.

Provisions

Provisions are recognized when the Company has liabilities (legal or substantial) due to some past event and there is a probability that the performance of these liabilities will require outflow of economic resources from the Company, and the amount of liabilities can be fairly assessed.

Corporate income tax

Corporate income tax for the reporting period consists of the tax calculated for the reporting period and deferred tax. Corporate income tax is recognized in the profit or loss account.

Calculated tax

The tax calculated for the reporting period has been calculated in compliance with the requirements of the Law "On Corporate Income Tax" by fixing the taxable income and applying the statutory rate of 15%.

Deferred tax

Deferred corporate income tax is calculated for temporary time differences, which are caused due to differences in the value of assets and liabilities in the financial statements (book-keeping) and its value for tax purposes. The mentioned differences are mainly due to different fixed assets depreciation rates applied in tax and financial accounting, provisions made and losses transferred according to the Company's income tax declaration. Deferred tax is calculated by applying the statutory tax rate 15%.

Subsidies

Amounts, which are received as a state support for agricultural, i.e., for covering of expenses for maintaining highquality breed bulls, are included in the income of that reporting period when they are received.

Use of assumptions

When preparing the financial statements, the Company's management has to make calculations and assumptions, which impact recognition of assets and liabilities included in the financial statements as at the day of preparing the financial statements, as well as the income and expenses recognized in the specific reporting period. Management has made profit or loss assessment and considers that the financial statements reflect the true financial condition based on all currently available information.

(3) Net sales

Sales include income gained during the year from the Company's basic activities – sales of products and provision of services without value added tax and less discounts.

Type of operations	2014 EUR	2013 EUR
Livestock sperm	293 482	267 008
Milk laboratory services	139 434	133 880
Treatment of supervisory data	57 576	51 996
Cow exterior appraisal	3 591	2 619
Artificial insemination of livestock	20 552	21 496
Other income	34 613	39 492
	549 248	516 491
Distribution of net sales according to the geographical markets:
	2014 EUR	2013 EUR
Latvia	549 248	516 491
	549 248	516 491
Earnings from agricultural activities represented in net sales:
	2014 EUR	2013 EUR
Earnings from agricultural activities	549 248	516 491
	549 248	516 491

(4) Changes in stock of ready-made goods and unfinished products

	2014	2013
	EUR	EUR
Changes in sperm stock value	28 974	30 805
Written-off sperm	-	(7 962)
Changes in stud bull herd value	14 940	13 525
	43 914	36 368

(5) Other operating income

	2014 EUR	2013 EUR
State support for agricultural	4 300	3 491
	4 300	3 491

(6) Personnel costs

	2014 EUR	2013 EUR
Salaries for work	170 725	160 726
Life insurance with cash value accrual	6 305	7 048
State social insurance contributions	39 969	38 460
Health insurance	7 645	7 427
Other costs	1 546	1 503
	226 190	215 164

(7) Other operating expenses

	2014	2013
	EUR	EUR
Insurance payments	1 424	1 298
Business trip expenses	1 419	1 656
Selling expenses	1 313	2 285
The costs of accreditation and employee training	1 220	1 162
The costs of security services	635	635
Taxes applied on the vehicles	512	583
Company's management and administrative expenses	12 813	11 744
Other costs	5 052	3 638
	24 388	23 001

(8) Other interest income and similar income

	2014 EUR	2013 EUR
Income from securities	26	37
Income from foreign currency exchange rate fluctuations	29	-
Recovered doubtful and bad debts	2 364	1 362
Other income	3	-
	2 422	1 399

(9) Interest payments and similar costs

	2014 EUR	2013 EUR
Losses from foreign currency exchange rate fluctuations	-	343
Employees' leisure and other costs not connected with operating activities	2 515	1 925
	2 515	2 268

(10) Other taxes

2014 EUR	2013 EUR
1 635	1 612
1 635	1 612

(11) Intangible assets

	Concessions, patents, licenses, trade marks and similar rights	Total
	EUR	EUR
Initial value
31.12.2013	1 025	1 025
Purchased	-	-
Disposed	-	-
30.06.2014	1 025	1 025
Accrued depreciation
31.12.2013	1 025	1 025
Calculated depreciation	-	-
Depreciation of excluded investments	-	-
30.06.2014	1 025	1 025
Book value as at 31.12.2013	-	-
Book value as at 30.06.2014	-	-

(12) Report on movement of fixed assets

	Land, buildings and constructions	Technological equipment and machinery	Other fixed assets	Fixed assets in formation	Total
	EUR	EUR	EUR	EUR	EUR
Initial value
31.12.2013	378 017	479 524	122 811	-	980 352
Purchased	-	-	2 917	1 668	4 585
Disposed	-	(33 529)	(720)	-	(34 249)
30.06.2014	378 017	445 995	125 008	1 668	950 688
Accrued depreciation
31.12.2013	221 249	418 303	112 456	-	752 008
Calculated depreciation	7 938	11 915	2 626	-	22 479
Depreciation of excluded fixed
assets	-	(33 529)	(720)	-	(34 249)
30.06.2014	229 187	396 689	114 362	-	740 238
Book value as at 31.12.2013	156 768	61 221	10 355	-	228 344
Book value as at 30.06.2014	148 830	49 306	10 646	1 668	210 450

As at 30 June 2013, the cadastral value of real estate – land and constructions - was EUR 157 893 As at 30 June 2014, the cadastral value of real estate – land and constructions - was EUR 158 004

(13) Investment properties

	Land	Total
	EUR	EUR
Book value as at 31.12.2012	120 944	120 944
Increase/decrease of value due to revaluation	-	-
Book value as at 30.06.2013	120 944	120 944
Book value as at 31.12.2013	86 795	86 795
Increase/decrease of value due to revaluation	-	-
Book value as at 30.06.2014	86 795	86 795

(14) Investments in capital of associated companies

	2014			2013
	% from total share capital		% from total share
		EUR	capital	EUR
Ltd "Animal Breeders Association of Latvia"
(SIA "Latvijas šķirnes dzīvnieku audzētāju savienība" )
Legal address: Republikas laukums 2, Rīga, LV-1010,
Latvia	36.3	83 954	36.3	83 954
		83 954		83 954

(15) Other securities and investments

	EUR
Purchase value as at 30.06.2013	683
Book value as at 30.06.2013	683
Purchase value as at 30.06.2014	683
Book value as at 30.06.2014	683

(16) Ready-made products and goods for sale

	2014 EUR	2013 EUR
Bull semen	543 224	504 792
Other goods for sale	16 933	13 743
	560 157	518 535

(17) Trade receivables

	2014 EUR	2013 EUR
Accounting value of trade receivables	208 052	171 355
Provisions for doubtful trade receivables	(8 108)	(5 178)
	199 944	166 177

(18) Other receivables

	2014 EUR	2013 EUR
VAT for received goods and services	220	976
Other receivables	171	751
	391	1 727

(19) Prepaid expenses

The item recognizes the costs made during the reporting year, but referring to the next reporting periods.

	2014 EUR	2013 EUR
Advertising costs	75	296
Insurance	3 267	3 118
Press and legislation updates' subscription	15	89
Other prepaid expenses	86	126
	3 443	3 629

(20) Other securities and shareholding in capitals

		2014			2013
	Number	Market	Amount	Number	Market	Amount
		price	EUR		price	EUR
SEB Euro reserve fund	15 044	2.07005	31 142	15 044	2.06738	31 102
			31 142			31 102

Money market fund shares have no guaranteed interest rate. In 2014 the profitability was 0.16 %. Exclusion of money market fund shares is carried out at the Company's request.

(21) Cash in EUR and foreign currencies according to the European Central Bank's foreign exchange reference rates

Break-down of cash according to currencies:		2014		2013
		Currency	EUR	Currency	EUR
Cash in hand	LVL	-	-	6 031	8 581
Cash in hand	EUR	-	5 282	-	-
Cash in bank	LVL	-	-	100 692	143 272
Cash in bank	EUR	-	198 707	-	435
			203 989		152 288

(22) Share capital

The Company's shares are quoted on NASDAQ OMX Riga Stock Exchange's second listing. The Company's share capital consists of shareholders' investments. The total number of shares is 422 440, the nominal value per share is 1 Lat (1.42 euro).

	2014 EUR	2013 EUR
Ordinary common shares with voting rights	599 655	599 655
Shares owned by the Board without voting rights	1 423	1 423
	601 078	601 078

421440 shares or 99.8% of the share capital are bearer shares, which give equal rights to receive dividends, receipt of liquidation quota and voting rights in the Shareholders' Meeting.

1000 shares or 0.2% of the share capital, which are not included in the regulated market, are personnel registered shares, which may be obtained only by Members of the Board, and they give equal rights only to receipt of dividend and liquidation quota.

There are no share alienation restrictions, nor the necessity to receive the Company's or other shareholders' consent for alienation of shares.

There are no restrictions on voting rights, nor any other similar restrictions.

Profit per share

Profit per one share is calculated by dividing the profit of the reporting period with the average weighted number of shares during the year.

	2014 EUR	2013 EUR
Profit of the reporting period	84 677	42 006
Average weighted number of shares during the year	422 440	422 440
	0.200	0.099

(23) Other Provisions

EUR
8 176
8 176

(24) Provisions for deferred tax

	2014 EUR	2013 EUR
Temporary differences in fixed assets depreciation	37 263	37 195
Provisions for vacations	(6 926)	(8 176)
Total temporary differences	30 337	29 019
Deferred tax provisions at the beginning of the period	4 550	4 353
Increase or decrease	-	-
Deferred tax provisions at the end of the period	4 550	4 353

(25) Taxes and social insurance payments

Tax type	Balance as at	Calculated in	Paid in	Balance as at
	31.12.2013	2014	2014	30.06.2014
	EUR	EUR	EUR	EUR
Corporate income tax	(999)	7 872	(6 873)	-
Value added tax	13 076	76 954	(77 972)	12 058
Social insurance contributions	-	57 757	(48 191)	9 566
Personal income tax	-	32 804	(27 344)	5 460
Real estate tax	-	1 635	(1 635)	-
Nature resource tax	28	108	(99)	37
Business risk duty	-	77	(63)	14
Tax for the exploitation of the vehicles	-	256	(256)	-
Tax applied on company owned motorcars	-	256	(256)	-
	12 105	177 719	(162 689)	27 135
Including:	2013			2014
	EUR			EUR
Tax overpaid	(999)			-
Tax due	13 104			27 135

Tax overpaid declared in position "Other receivables"

(26) Number of persons employed by the Company

	2014	2013
Average number of persons employed during the reporting year	35	34

(27) Information on remuneration to Council, Board and Managements Members

	2014 EUR	2013 EUR
Council Members' salaries for work, including state social insurance
contributions	5 068	5 239
Board Members' salaries for work, including state social insurance
contributions	23 208	20 022
Total remuneration to management members	28 276	25 261

There are no special regulations worked out, which would regulate election of Board Members, changes in the composition of the Board and amending of the Articles of Association.

All Board Members have equal Company's representation rights. The Chairman of the Board represents the Company separately, but other Board Members can represent the Company only both together.

There is no agreement signed between the Company and the Board Members, which provides any compensation.

Report on Management Liability

According to the information being at our disposal, the Interim statement for six months of 2014 have been prepared according to the effective requirements of legislative enactments and provide a true and fair view about the joint stock company's "Siguldas ciltslietu un mākslīgās apsēklošanas stacija" assets, liabilities, financial condition and profit.

Interim statement for six months of 2014 have not been audited by Sworn Auditor.

Nils Ivars Feodorovs Sarmīte Arcimoviča Valda Mālniece

Chairman of the Board Member of the Board, Head of Production and Marketing Department

Member of the Board, Head of Financial and Accounting Department